The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Integrated analysis of germline and somatic variants in ovarian cancer
Open accessAbstract
We report the first large-scale exome-wide analysis of the combined germline–somatic landscape in ovarian cancer. Here we analyse germline and somatic alterations in 429 ovarian carcinoma cases and 557 controls. We identify 3,635 high confidence, rare truncation and 22,953 missense variants with predicted functional impact. We find germline truncation variants and large deletions across Fanconi pathway genes in 20% of cases. Enrichment of rare truncations is shown in BRCA1, BRCA2 and PALB2. In addition, we observe germline truncation variants in genes not previously associated with ovarian cancer susceptibility (NF1, MAP3K4, CDKN2B and MLL3). Evidence for loss of heterozygosity was found in 100 and 76% of cases with germline BRCA1 and BRCA2 truncations, respectively. Germline–somatic interaction analysis combined with extensive bioinformatics annotation identifies 222 candidate functional germline truncation and missense variants, including two pathogenic BRCA1 and 1 TP53 deleterious variants. Finally, integrated analyses of germline and somatic variants identify significantly altered pathways, including the Fanconi, MAPK and MLL pathways. Ovarian cancer is one of the most common cancers in women and has an average 5-year survival of only 43%. Here, Kanchi et al.describe the germline and somatic mutation spectrum in ovarian cancer patients and identify potential risk variants associated with the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
Thorvaldsdottir, H., Robinson, J. T., & Mesirov, J. P. (2013) · Briefings in Bioinformatics · doi:10.1093/bib/bbs017 · Cited by 9,049
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
SIFT: predicting amino acid changes that affect protein function
Ng, P. C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg509 · Cited by 6,577
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,905
Self-citationMutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Self-citationComprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Somatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
Self-citationGenome-wide association study identifies novel breast cancer susceptibility loci
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319
Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor
McLaren, W., Pritchard, B., Rios, D., Chen, Y., Flicek, P., & Cunningham, F. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq330 · Cited by 1,586
Stenson, P. D., Mort, M., Ball, E. V., Shaw, K., Phillips, A. D., & Cooper, D. N. (2014) · Human Genetics · doi:10.1007/s00439-013-1358-4 · Cited by 1,346
LOVD v.2.0: the next generation in gene variant databases
Fokkema, I. F. A. C., Taschner, P. E. M., Schaafsma, G. C. P., Celli, J., Laros, J. F. J., & den Dunnen, J. T. (2011) · Human Mutation · doi:10.1002/humu.21438 · Cited by 1,048
Whole-genome analysis informs breast cancer response to aromatase inhibition
Ellis, M. J., Ding, L., Shen, D., Luo, J., Suman, V. J., Wallis, J. W., Van Tine, B. A., Hoog, J., Goiffon, R. J., Goldstein, T. C., et al. (2012) · Nature · doi:10.1038/nature11143 · Cited by 1,023
Self-citationWalsh, T., Casadei, S., Lee, M. K., Pennil, C. C., Nord, A. S., Thornton, A. M., Roeb, W., Agnew, K. J., Stray, S. M., Wickramanayake, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115052108 · Cited by 933
Nickerson, D. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.14.2745 · Cited by 931
National Human Genome Research Institute
National Cancer Institute (2020) · Definitions · doi:10.32388/mrapt2 · Cited by 861
González-Pérez, A., & López-Bigas, N. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.03.004 · Cited by 765
The women's health initiative recruitment methods and results
Hays, J., Hunt, J. R., Hubbell, F. A., Anderson, G. L., Limacher, M., Allen, C., & Rossouw, J. E. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00042-5 · Cited by 742
MuSiC: Identifying mutational significance in cancer genomes
Dees, N. D., Zhang, Q., Kandoth, C., Wendl, M. C., Schierding, W., Koboldt, D. C., Mooney, T. B., Callaway, M. B., Dooling, D., Mardis, E. R., et al. (2012) · Genome Research · doi:10.1101/gr.134635.111 · Cited by 677
Self-citationThomas, G., Jacobs, K. B., Kraft, P., Yeager, M., Wacholder, S., Cox, D. G., Hankinson, S. E., Hutchinson, A., Wang, Z., Yu, K., et al. (2009) · Nature Genetics · doi:10.1038/ng.353 · Cited by 536
Morgenthaler, S., & Thilly, W. G. (2007) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2006.09.003 · Cited by 507 · cited 2×
“Further analysis of 535 missense variants from cancer genes, using the same criteria applied for truncations, identified 35 and 14 missense events in COSMIC and OMIM, respectively (Supplementary Data 11).”
Thirman, M. J., Gill, H. J., Burnett, R. C., Mbangkollo, D., McCabe, N. R., Kobayashi, H., Ziemin-van der Poel, S., Kaneko, Y., Morgan, R., Sandberg, A. A., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309233291302 · Cited by 502
Easton, D. F., Deffenbaugh, A. M., Pruss, D., Frye, C., Wenstrup, R. J., Allen-Brady, K., Tavtigian, S. V., Monteiro, A. N. A., Iversen, E. S., Couch, F. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/521032 · Cited by 455
De Novo Discovery of Mutated Driver Pathways in Cancer
Vandin, F., Upfal, E., & Raphael, B. J. (2011) · Lecture Notes in Computer Science · doi:10.1007/978-3-642-20036-6_44 · Cited by 434
Self-citationAlgorithms for Detecting Significantly Mutated Pathways in Cancer
Vandin, F., Upfal, E., & Raphael, B. J. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0265 · Cited by 430
Self-citationMutations of ASXL1 gene in myeloproliferative neoplasms
Carbuccia, N., Murati, A., Trouplin, V, Brecqueville, M., Adélaïde, J., Rey, J., Vainchenker, W., Bernard, O. A., Chaffanet, M., Vey, N., et al. (2009) · Leukemia · doi:10.1038/leu.2009.141 · Cited by 331
Metzeler, K. H., Maharry, K., Radmacher, M. D., Mrózek, K., Margeson, D., Becker, H., Curfman, J., Holland, K. B., Schwind, S., Whitman, S. P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.7742 · Cited by 280
Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
Thol, F., Friesen, I., Damm, F., Yun, H., Weissinger, E. M., Krauter, J., Wagner, K., Chaturvedi, A., Sharma, A., Wichmann, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.4938 · Cited by 277
Duns, G., van den Berg, E., van Duivenbode, I., Osinga, J., Hollema, H., Hofstra, R. M. W., & Kok, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0120 · Cited by 239
Patnaik, M. M., Padron, E., LaBorde, R. R., Lasho, T. L., Finke, C. M., Hanson, C. A., Hodnefield, J. M., Knudson, R. A., Ketterling, R. P., Al-kali, A., et al. (2013) · Leukemia · doi:10.1038/leu.2013.88 · Cited by 218
Seminog, O. O., & Goldacre, M. J. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.535 · Cited by 218
Thompson, E. R., Doyle, M. A., Ryland, G. L., Rowley, S. M., Choong, D. Y. H., Tothill, R. W., Thorne, H., kConFab, Barnes, D. R., Li, J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002894 · Cited by 211
Schnittger, S., Eder, C., Jeromin, S., Alpermann, T., Fasan, A., Grossmann, V, Kohlmann, A., Illig, T., Klopp, N., Wichmann, H.-E., et al. (2013) · Leukemia · doi:10.1038/leu.2012.262 · Cited by 211
The Breast Cancer Information Core: Database design, structure, and scope
Szabo, C., Masiello, A., Ryan, J. F., The BIC Consortium, & Brody, L. C. (2000) · Human Mutation · doi:10.1002/1098-1004(200008)16:2<123::aid-humu4>3.0.co;2-y · Cited by 193
Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis
Fearnhead, N. S., Wilding, J. L., & Bodmer, W. F. (2002) · British Medical Bulletin · doi:10.1093/bmb/64.1.27 · Cited by 179
Hereditary ovarian cancer: Beyond the usual suspects
Pennington, K. P., & Swisher, E. M. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.12.415 · Cited by 159
PathScan: a tool for discerning mutational significance in groups of putative cancer genes
Wendl, M. C., Wallis, J. W., Lin, L., Kandoth, C., Mardis, E. R., Wilson, R. K., & Li, J. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr193 · Cited by 92
Self-citationPenzel, R., Sers, C., Chen, Y., Lehmann-Mühlenhoff, U., Merkelbach‐Bruse, S., Jung, A., Kirchner, T., Büttner, R., Kreipe, H. H., Petersen, I., et al. (2010) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-010-1000-y · Cited by 85
Germline mutation in the RAD51B gene confers predisposition to breast cancer
Golmard, L., Caux‐Moncoutier, V., Davy, G., Ageeli, E. A., Poirot, B., Tirapo, C., Michaux, D., Barbaroux, C., d’Enghien, C. D., Nicolas, A., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-484 · Cited by 82
Nellist, M. D., Sancak, Ő., Goedbloed, M., Rohé, C. F., van Netten, D., Mayer, K., Williams, A. T., van den Ouweland, A. M. W., & Halley, D. J. J. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201276 · Cited by 80
PolyScan: An automatic indel and SNP detection approach to the analysis of human resequencing dataPreprint
Chen, K., McLellan, M. D., Ding, L., Wendl, M. C., Kasai, Y., Wilson, R. K., & Mardis, E. R. (2007) · Genome Research · doi:10.1101/gr.6151507 · Cited by 80
Self-citationMian, S. A., Smith, A., Kulasekararaj, A. G., Kizilors, A., Mohamedali, A. M., Lea, N. C., Mitsopoulos, C., Ford, K., Nasser, E. E., Seidl, T., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.075325 · Cited by 77
Jozwiak, J., Jozwiak, S., Grzela, T., & Lazarczyk, M. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:4:287 · Cited by 63
Genetic Testing by Cancer Site
Weissman, S. M., Weiss, S. M., & Newlin, A. C. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31826246c2 · Cited by 62
Durocher, F., Labrie, Y., Soucy, P., Sinilnikova, O. M., Labuda, D., Bessette, P., Chiquette, J., Laframboise, R., Lépine, J., Lespérance, B., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-230 · Cited by 56
Hellebrand, H., Sutter, C., Honisch, E., Groß, E., Wappenschmidt, B., Schem, C., Deißler, H., Ditsch, N. C., Gress, V., Kiechle, M. B., et al. (2011) · Human Mutation · doi:10.1002/humu.21478 · Cited by 55
Prevalence of germline TP53 mutations in HER2+ breast cancer patients
Rath, M., Masciari, S., Gelman, R. S., Miron, A., Miron, P. L., Foley, K. M., Richardson, A. L., Krop, I. E., Verselis, S. J., Dillon, D. A. R., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2375-z · Cited by 52
Mutations in the Hedgehog Pathway Genes SMO and PTCH1 in Human Gastric Tumors
Wang, X.-D., Inzunza, H. D., Han, C. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054415 · Cited by 46
FANCD2 associated with sporadic breast cancer risk
Barroso, E., Milne, R. L., Fernández, L. P., Zamora, P., Arias, J. I., Benítez, J., & Ribas, G. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl062 · Cited by 45
Nakken, S., Alseth, I., & Rognes, T. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.004 · Cited by 42
Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.
Offit, K., Gilad, S., Paglin, S., Kolachana, P., Roisman, L. C., Nafa, K., Yeugelewitz, V., Gonzales, M. L. A., Robson, M. E., McDermott, D. A., et al. (2002) · PubMed · Cited by 40
Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families
Catucci, I., Milgrom, R., Kushnir, A., Laitman, Y., Paluch–Shimon, S., Volorio, S., Ficarazzi, F., Bernard, L., Radice, P., Friedman, E., et al. (2012) · Familial Cancer · doi:10.1007/s10689-012-9540-8 · Cited by 32
Sólyom, S., Winqvist, R., Nikkilä, J., Rapakko, K., Hirvikoski, P. P., Kokkonen, H., & Pylkäs, K. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.12.020 · Cited by 30
Rzepecka, I. K., Szafron, L. M., Styś, A., Bujko, M., Plisiecka-Hałasa, J., Mądry, R., Osuch, B., Markowska, J., Bidziński, M., & Kupryjańczyk, J. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2011.12.005 · Cited by 22
Cited by
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Self-citationGermline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
Self-citationVariant Review with the Integrative Genomics Viewer
Robinson, J. T., Thorvaldsdóttir, H., Wenger, A. M., Zehir, A., & Mesirov, J. P. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0337 · Cited by 1,115
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Lisio, M.-A., Fu, L., Goyeneche, A., Gao, Z.-H., & Telleria, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040952 · Cited by 680
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., Garber, J. E., Kauff, N. D., Khan, S., Klein, C., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0003 · Cited by 650
Metadata
- Authors
- Kanchi, K. L., Johnson, K. J., Lu, C., McLellan, M. D., Leiserson, M. D. M., Wendl, M. C., Zhang, Q., Koboldt, D. C., Xie, M., Kandoth, C., McMichael, J. F., Wyczalkowski, M. A., Larson, D. E., Schmidt, H. K., Miller, C. A., Fulton, R. S., Spellman, P. T., Mardis, E. R., Druley, T. E., Graubert, T. A., Goodfellow, P. J., Raphael, B. J., Wilson, R. K., & Ding, L.
- Venue
- Nature Communications
- Published
- 2014-01-22
- Volume
- 5
- Issue
- 1
- Pages
- 3156-3156
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2126633009
- Cited by
- 296
- References
- 62
- FWCI
- 18.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.